Ceftriaxone

Common Uses

Ceftriaxone is an injectable antibiotic used to treat infections caused by bacteria. It is effective against many different types of bacteria and is often used for:

• Respiratory infections: Such as pneumonia.
• Skin infections: Including infections of the skin and underlying tissues.
• Urinary tract infections: To treat bacterial growth in the bladder or kidneys.
• Bone and joint infections: Such as osteomyelitis.
• Meningitis: An infection of the lining of the brain and spinal cord.
• Septicemia: A serious blood infection.
• Abdominal infections: Including peritonitis and gallbladder infections.
• Sexually transmitted infections: Specifically gonorrhea and pelvic inflammatory disease.
• Ear infections: Used for acute bacterial middle ear infections.

Surgical Prevention

Healthcare providers may also use ceftriaxone before certain surgeries to reduce the risk of infection following the procedure.

This medication is only effective against bacterial infections. It will not work for viral infections such as the common cold, flu, or most coughs and sore throats.

Mechanism of Action

Ceftriaxone belongs to a group of medicines called cephalosporin antibiotics. It works by attacking the structural integrity of bacteria to eliminate an infection.

Targeting the Cell Wall

Bacteria require a strong outer layer called a cell wall to survive, maintain their shape, and protect themselves from their environment. Ceftriaxone works by interfering with the final stages of how bacteria build these walls. Specifically, it:

• Binds to specific proteins that bacteria use to construct their cell walls.
• Prevents the bacteria from cross-linking the components of the wall together.
• Causes the cell wall to become unstable and eventually burst.

By breaking down the cell wall, ceftriaxone kills the bacteria directly. This is known as a bactericidal effect.

Limitations

Ceftriaxone is designed to target structures found only in bacteria. Because human cells do not have cell walls, the medication does not affect human cells in the same way. It is important to note that this medication only works against bacterial infections and is not effective against viruses, such as those that cause the flu or the common cold.

Common Side Effects

Many people using ceftriaxone do not experience significant side effects. When they do occur, common symptoms may include:

• Pain, swelling, or a hard lump where the injection was given
• Diarrhea
• Nausea or vomiting
• Upset stomach
• Headache
• Dizziness
• Vaginal itching or discharge
• Changes in taste
• Sweating or flushing

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious symptoms:

• Signs of an allergic reaction, such as hives, skin rash, swelling of the face, lips, or throat, or difficulty breathing
• Severe stomach pain and watery or bloody diarrhea, which may occur during treatment or up to several months after the last dose
• Yellowing of the skin or eyes (jaundice)
• Dark-colored urine or pale stools
• New or worsening fever, chills, or sore throat
• Unusual bruising or bleeding
• Pain in the upper right side of the stomach
• Seizures
• Decreased urination or painful urination

In rare cases, ceftriaxone can cause severe skin reactions that involve blistering or peeling. Seek emergency medical help if you notice a red or purple skin rash that spreads and causes blistering. Additionally, this medication can sometimes cause gallbladder problems, particularly in children; symptoms may include sudden, severe pain in the upper abdomen.

Calcium Interaction in Neonates

Ceftriaxone is contraindicated in newborns (28 days old or younger) who require treatment with calcium-containing intravenous solutions. Combining these can lead to life-threatening mineral deposits in the lungs and kidneys. It is also avoided in neonates with high bilirubin levels, particularly those born prematurely, as it may cause brain damage.

Hypersensitivity and Allergic Reactions

Serious and occasionally fatal hypersensitivity reactions, including anaphylaxis, have been reported. Individuals with a history of severe reactions to penicillin or other beta-lactam antibiotics should use ceftriaxone with extreme caution due to the potential for cross-reactivity.

Gallbladder and Pancreas Complications

Ceftriaxone can cause particles to form in the gallbladder, a condition known as biliary sludging or pseudolithiasis. While this usually resolves after the medication is stopped, it can cause symptoms similar to gallbladder disease. Rare cases of pancreatitis have also been reported, potentially linked to biliary obstruction.

Antibiotic-Associated Diarrhea

Treatment with ceftriaxone can alter the normal bacteria in the colon, leading to overgrowth of Clostridioides difficile. This can cause Clostridioides difficile-associated diarrhea (CDAD), which ranges in severity from mild diarrhea to life-threatening inflammation of the colon.

Blood and Neurological Risks

• Hemolytic Anemia: Immune-mediated hemolytic anemia, a condition where red blood cells are destroyed by the immune system, has been observed and can be fatal.
• Seizures: There is a risk of seizures, particularly in patients with kidney impairment who receive high doses of the medication.
• Prothrombin Time: Changes in blood clotting (prothrombin time) may occur, especially in patients with nutritional deficiencies or liver/kidney disease.

Pregnancy

Studies in animals have not shown evidence of harm to the fetus when ceftriaxone is used. However, there are no adequate and well-controlled studies in pregnant women. Because animal studies do not always predict human response, ceftriaxone should be used during pregnancy only if a healthcare provider determines it is clearly necessary.

Breastfeeding

Ceftriaxone passes into breast milk in low concentrations. While it is generally considered compatible with breastfeeding, the medication may cause changes in the infant's gut bacteria or lead to an allergic reaction. Potential side effects to watch for in a nursing infant include:

• Diarrhea
• Diaper rash or thrush (yeast infections)
• Unusual fussiness

Parents should discuss the benefits and risks of breastfeeding while using ceftriaxone with their doctor.

Special Considerations for Newborns

Ceftriaxone can displace bilirubin from its binding sites in the blood. This is a significant concern for newborns, especially those born prematurely, as it can increase the risk of a serious condition called kernicterus (a type of brain damage caused by high bilirubin). While this risk is most critical when the drug is administered directly to the infant, healthcare providers consider this factor when prescribing the medication to breastfeeding parents or those near delivery.

Available Forms

Ceftriaxone is provided in several injectable formats for administration by a healthcare professional:

• Powder for Injection: This form is supplied in vials and must be reconstituted with a compatible diluent before administration. It can be given as an intramuscular injection or an intravenous injection.
• Premixed Injection: This form is supplied in containers as a frozen or ready-to-use solution for intravenous infusion.
• Pharmacy Bulk Packages: These are larger containers of powder intended for use in a pharmacy setting to prepare multiple doses for intravenous use.

FDA Approval and Indications

Ceftriaxone is a third-generation cephalosporin antibiotic that received FDA approval for the treatment of various infections caused by susceptible organisms. It is commonly used for:

• Lower respiratory tract infections, such as pneumonia
• Skin and skin structure infections
• Urinary tract and renal infections
• Pelvic inflammatory disease and gonorrhea
• Bacterial septicemia
• Bone and joint infections
• Intra-abdominal infections
• Meningitis

It is also FDA-approved for use as a surgical prophylaxis to reduce the risk of post-operative infections in patients undergoing certain procedures.

Regulatory Safety Information

Ceftriaxone does not have a boxed warning. However, the FDA has established a strict contraindication for its use in neonates (infants 28 days old or younger). It must not be administered simultaneously with calcium-containing intravenous solutions in this age group due to the risk of fatal organ damage caused by the formation of ceftriaxone-calcium precipitates.

Ceftriaxone is available only by prescription and is administered via intramuscular injection or intravenous infusion. There is no Risk Evaluation and Mitigation Strategy (REMS) program currently required for this medication.

There is no documented direct interaction between ceftriaxone and alcohol. Unlike certain other cephalosporin antibiotics, ceftriaxone does not typically cause a disulfiram-like reaction (which includes symptoms like severe nausea, vomiting, and flushing) when alcohol is consumed.

While there is no specific contraindication, healthcare providers generally recommend avoiding alcohol while treating an infection for the following reasons:

• Managing side effects: Ceftriaxone can cause side effects such as nausea, dizziness, or diarrhea. Alcohol may worsen these symptoms or make it harder to determine if a symptom is caused by the medication or the alcohol.
• Supporting the immune system: Alcohol can cause dehydration and disrupt sleep, both of which are important for the body's ability to fight an infection.

It is best to consult with a healthcare professional for guidance based on your specific condition and treatment plan.